KVUE Kenvue

Q2 2025 10-Q

Filed: Aug 7, 2025Period ending Jun 29, 2025

Health Care

Perfumes, Cosmetics & Other Toilet PreparationsSEC EDGAR

Kenvue (KVUE) 10-Q quarterly report for Q2 2025, filed with SEC EDGAR on Aug 7, 2025 for the fiscal period ending Jun 29, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q2 2025 10-Q

Risk Factors

• New strategic review risk triggered by July 2025 Board-initiated comprehensive review of alternatives including brand portfolio optimization
• Strategic review process risk: potential delays, distractions, increased costs possibly harming business and stock price volatility

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$3.8B

Net Income

$420M

Net Margin

10.9%

Source: XBRL data from Kenvue Q2 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Kenvue Quarterly Reports

Q3 2025 10-Q

Get deeper insights on Kenvue

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.